CWA Asset Management Group LLC bought a new position in shares of The Cigna Group (NYSE:CI – Free Report) during the third quarter, according to its most recent Form 13F filing with the SEC. The fund bought 7,633 shares of the health services provider’s stock, valued at approximately $2,644,000.
Other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. Van ECK Associates Corp increased its holdings in The Cigna Group by 4.4% in the second quarter. Van ECK Associates Corp now owns 14,872 shares of the health services provider’s stock valued at $4,916,000 after purchasing an additional 625 shares during the period. Marks Group Wealth Management Inc increased its stake in shares of The Cigna Group by 3,669.7% in the third quarter. Marks Group Wealth Management Inc now owns 24,013 shares of the health services provider’s stock valued at $8,319,000 after buying an additional 23,376 shares during the period. Hancock Whitney Corp increased its stake in shares of The Cigna Group by 75.6% in the first quarter. Hancock Whitney Corp now owns 3,783 shares of the health services provider’s stock valued at $1,374,000 after buying an additional 1,629 shares during the period. ORG Partners LLC bought a new position in shares of The Cigna Group during the second quarter worth about $489,000. Finally, Tidal Investments LLC lifted its stake in shares of The Cigna Group by 36.0% in the first quarter. Tidal Investments LLC now owns 15,276 shares of the health services provider’s stock worth $5,548,000 after acquiring an additional 4,043 shares during the period. 86.99% of the stock is currently owned by institutional investors and hedge funds.
The Cigna Group Price Performance
The Cigna Group stock opened at $319.77 on Friday. The company has a current ratio of 0.72, a quick ratio of 0.72 and a debt-to-equity ratio of 0.71. The business’s 50 day simple moving average is $341.73 and its 200 day simple moving average is $340.43. The Cigna Group has a 12 month low of $253.95 and a 12 month high of $370.83. The company has a market cap of $88.94 billion, a price-to-earnings ratio of 30.17, a PEG ratio of 0.95 and a beta of 0.51.
The Cigna Group Announces Dividend
The firm also recently declared a quarterly dividend, which will be paid on Thursday, December 19th. Investors of record on Wednesday, December 4th will be paid a dividend of $1.40 per share. This represents a $5.60 dividend on an annualized basis and a dividend yield of 1.75%. The ex-dividend date is Wednesday, December 4th. The Cigna Group’s payout ratio is currently 52.83%.
Insider Buying and Selling
In other The Cigna Group news, Director William J. Delaney III sold 2,691 shares of the business’s stock in a transaction on Monday, August 19th. The shares were sold at an average price of $342.68, for a total transaction of $922,151.88. Following the sale, the director now owns 17,539 shares of the company’s stock, valued at $6,010,264.52. The trade was a 0.00 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available through this link. 0.60% of the stock is owned by insiders.
Wall Street Analysts Forecast Growth
A number of research firms have weighed in on CI. Cantor Fitzgerald reissued an “overweight” rating and set a $400.00 target price on shares of The Cigna Group in a research report on Wednesday, October 23rd. Deutsche Bank Aktiengesellschaft lowered their target price on shares of The Cigna Group from $398.00 to $394.00 and set a “buy” rating for the company in a research note on Monday, November 4th. StockNews.com cut shares of The Cigna Group from a “strong-buy” rating to a “buy” rating in a research report on Monday, November 4th. Barclays lifted their price objective on The Cigna Group from $405.00 to $420.00 and gave the stock an “overweight” rating in a research report on Tuesday, November 5th. Finally, Piper Sandler reissued an “overweight” rating and issued a $394.00 price objective (up from $392.00) on shares of The Cigna Group in a research note on Tuesday, November 5th. One analyst has rated the stock with a hold rating, fourteen have issued a buy rating and one has issued a strong buy rating to the company. Based on data from MarketBeat, The Cigna Group currently has an average rating of “Buy” and a consensus target price of $394.64.
Check Out Our Latest Stock Report on The Cigna Group
The Cigna Group Company Profile
The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. Its Evernorth Health Services segment provides a range of coordinated and point solution health services, including pharmacy benefits, home delivery pharmacy, specialty pharmacy, distribution, and care delivery and management solutions to health plans, employers, government organizations, and health care providers.
Recommended Stories
- Five stocks we like better than The Cigna Group
- How to Invest in Tech Stocks and Top Tech Stocks to Consider
- Airbnb Stock Attracts Attention With Strong Cash Flow Strategy
- Stock Dividend Cuts Happen Are You Ready?
- MarketBeat Week in Review – 11/4 – 11/8
- How to Invest in Insurance Companies: A Guide
- Trump’s Return: Which Sectors Will Benefit Most?
Receive News & Ratings for The Cigna Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for The Cigna Group and related companies with MarketBeat.com's FREE daily email newsletter.